Y Intercept Hong Kong Ltd Has $10.97 Million Stock Position in The Clorox Company $CLX

Y Intercept Hong Kong Ltd raised its stake in The Clorox Company (NYSE:CLX) by 507.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 91,383 shares of the company’s stock after buying an additional 76,336 shares during the quarter. Y Intercept Hong Kong Ltd owned about 0.07% of Clorox worth $10,972,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in CLX. Vanguard Group Inc. boosted its stake in Clorox by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock worth $2,293,135,000 after purchasing an additional 65,924 shares during the period. Northern Trust Corp lifted its holdings in shares of Clorox by 2.3% in the first quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock valued at $225,133,000 after purchasing an additional 34,655 shares in the last quarter. Invesco Ltd. boosted its position in shares of Clorox by 7.4% during the first quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock worth $200,512,000 after buying an additional 94,371 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Clorox by 3.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock worth $170,406,000 after buying an additional 41,485 shares in the last quarter. Finally, Hsbc Holdings PLC raised its position in Clorox by 118.8% in the 1st quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock valued at $159,699,000 after buying an additional 589,544 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on CLX shares. TD Cowen decreased their price target on shares of Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research note on Wednesday, October 1st. Barclays decreased their target price on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research report on Tuesday, September 30th. Zacks Research raised shares of Clorox from a “strong sell” rating to a “hold” rating in a research report on Monday, September 29th. Citigroup decreased their price objective on Clorox from $135.00 to $130.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. Finally, BNP Paribas Exane dropped their target price on Clorox from $118.00 to $110.00 and set an “underperform” rating on the stock in a report on Friday, October 17th. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average price target of $130.20.

Clorox Stock Down 0.3%

Shares of CLX stock opened at $116.02 on Monday. The Clorox Company has a 52-week low of $115.83 and a 52-week high of $171.37. The stock has a market cap of $14.13 billion, a price-to-earnings ratio of 17.79, a PEG ratio of 0.96 and a beta of 0.52. The firm’s 50-day moving average is $121.18 and its 200-day moving average is $126.85. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same quarter in the previous year, the business earned $1.82 earnings per share. The business’s revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.3%. Clorox’s dividend payout ratio (DPR) is currently 76.07%.

Insider Buying and Selling

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.63% of the stock is currently owned by company insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.